659 related articles for article (PubMed ID: 31597272)
1. MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer.
Rahman MM; Brane AC; Tollefsbol TO
Cells; 2019 Oct; 8(10):. PubMed ID: 31597272
[TBL] [Abstract][Full Text] [Related]
2. Role of epigenetic modifications in luminal breast cancer.
Abdel-Hafiz HA; Horwitz KB
Epigenomics; 2015 Aug; 7(5):847-62. PubMed ID: 25689414
[TBL] [Abstract][Full Text] [Related]
3. The epigenetics of breast cancer.
Jovanovic J; Rønneberg JA; Tost J; Kristensen V
Mol Oncol; 2010 Jun; 4(3):242-54. PubMed ID: 20627830
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and miRNAs regulation in hereditary breast cancer: epigenetic changes, players in transcriptional and post- transcriptional regulation in hereditary breast cancer.
Pinto R; De Summa S; Pilato B; Tommasi S
Curr Mol Med; 2014 Jan; 14(1):45-57. PubMed ID: 24295492
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic mechanisms of breast cancer: an update of the current knowledge.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Ngollo M; Penault-Llorca F; Pajon A; Bignon YJ; Bernard-Gallon D
Epigenomics; 2014; 6(6):651-64. PubMed ID: 25531258
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation and histone modifications as epigenetic regulation in prostate cancer (Review).
Nowacka-Zawisza M; Wiśnik E
Oncol Rep; 2017 Nov; 38(5):2587-2596. PubMed ID: 29048620
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic inactivation of DNA repair in breast cancer.
Nowsheen S; Aziz K; Tran PT; Gorgoulis VG; Yang ES; Georgakilas AG
Cancer Lett; 2014 Jan; 342(2):213-22. PubMed ID: 22634493
[TBL] [Abstract][Full Text] [Related]
8. Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer.
Falahi F; van Kruchten M; Martinet N; Hospers GA; Rots MG
Breast Cancer Res; 2014 Jul; 16(4):412. PubMed ID: 25410383
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs and Epigenetics.
Moutinho C; Esteller M
Adv Cancer Res; 2017; 135():189-220. PubMed ID: 28882223
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer.
Liu W; Cui Y; Ren W; Irudayaraj J
Clin Epigenetics; 2019 Jan; 11(1):16. PubMed ID: 30700309
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Regulation of microRNAs in Cancer: Shortening the Distance from Bench to Bedside.
Pajares MJ; Alemany-Cosme E; Goñi S; Bandres E; Palanca-Ballester C; Sandoval J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298969
[TBL] [Abstract][Full Text] [Related]
12. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics and cancer.
Kanwal R; Gupta S
J Appl Physiol (1985); 2010 Aug; 109(2):598-605. PubMed ID: 20203073
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
[TBL] [Abstract][Full Text] [Related]
15. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.
Oh S; Ko JY; Oh C; Yoo KH
Adv Exp Med Biol; 2017; 1026():287-313. PubMed ID: 29282690
[TBL] [Abstract][Full Text] [Related]
16. [Epigenetic alterations in acute lymphoblastic leukemia].
Navarrete-Meneses MDP; Pérez-Vera P
Bol Med Hosp Infant Mex; 2017; 74(4):243-264. PubMed ID: 29382514
[TBL] [Abstract][Full Text] [Related]
17. Epigenetics and miRNAs in human cancer.
Fabbri M; Calin GA
Adv Genet; 2010; 70():87-99. PubMed ID: 20920746
[TBL] [Abstract][Full Text] [Related]
18. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398
[TBL] [Abstract][Full Text] [Related]
19. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
20. Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review.
Ramzan F; Vickers MH; Mithen RF
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
